세계의 수술 중 신경 모니터링 시장 규모, 점유율 및 동향 분석 보고서 : 소스 유형별, 최종 사용자별, 제품 및 서비스별, 용도별, 모달리티별, 지역별 전망 및 예측(2023-2030년)
Global Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Source Type, By End User, By Products & Services, By Application, By Modality, By Regional Outlook and Forecast, 2023 - 2030
상품코드:1429110
리서치사:KBV Research
발행일:2024년 01월
페이지 정보:영문 328 Pages
라이선스 & 가격 (부가세 별도)
한글목차
수술 중 신경 모니터링 시장 규모는 2030년까지 7억 달러에 달하고, 예측 기간 동안 6.0%의 성장률을 나타낼 것으로 예상됩니다.
그러나 규제 기관은 IONM 시스템을 포함한 의료기기 및 의료 절차에 대해 엄격한 요구 사항을 부과하는 경우가 많습니다. 제조업체는 이러한 기준을 충족하는 것이 어렵고 비용이 많이 들기 때문에 혁신적인 기술의 도입이 지연될 수 있습니다. 혁신적인 IONM 솔루션을 보유한 중소기업은 복잡한 규제 절차를 통과하는 데 어려움을 겪을 수 있습니다. 이는 중소기업 시장 진입 장벽이 되어 경쟁을 제한하고 기술 발전을 저해할 수 있습니다. 따라서 규제 준수와 표준화는 시장 성장을 저해하는 중요한 과제입니다.
또한, 의료기기, 특히 IONM 기기 및 액세서리의 가용성은 세계 공급망의 혼란으로 인해 영향을 받았습니다. 이로 인해 IONM 시스템의 조달 및 유지 보수에 지연이 발생했습니다. 병원과 의료 시설은 코로나19 환자 급증에 대응하기 위해 자원을 재분배해야 하는 어려움에 직면했습니다. 그 결과, 중요한 수술과 응급 수술에 중점을 두게 되었고, 선택적 수술과 응급 수술 이외의 수술에서 IONM의 사용에 영향을 미칠 수 있었습니다. 이처럼 코로나19 팬데믹은 시장에 적당한 영향을 미쳤습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요람
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
Porter의 Five Forces 분석
제4장 세계 시장 : 소스 유형별
세계의 위탁 모니터링 시장 : 지역별
세계의 아웃소싱 모니터링 시장 : 지역별
제5장 세계 시장 : 최종사용자별
세계의 병원 시장 : 지역별
세계의 외래수술센터(ASC) 시장 : 지역별
제6장 세계 시장 : 제품과 서비스별
세계의 서비스 시장 : 지역별
세계의 시스템 시장 : 지역별
세계의 액세서리 시장 : 지역별
제7장 세계 시장 : 용도별
세계의 척추 수술 시장 : 지역별
세계의 뇌신경외과 시장 : 지역별
세계의 정형외과 시장 : 지역별
세계의 이비인후과 수술 시장 : 지역별
세계의 혈관 외과 시장 : 지역별
세계의 기타 시장 : 지역별
제8장 세계 시장 : 모달리티별
세계의 근전계(EMG) 시장 : 지역별
세계의 뇌파 검사(EEG) 시장 : 지역별
세계의 운동 유발 전위(MEP) 시장 : 지역별
세계의 체질 감각 유발 전위(SSEP) 시장 : 지역별
세계의 시각 유발 전위(VEP) 시장 : 지역별
세계의 뇌의 중추부 청각 유발 전위(BAEP) 시장 : 지역별
제9장 세계 시장 : 지역별
북미
북미 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카/중동 및 아프리카
라틴아메리카/중동 및 아프리카 시장 : 국가별
브라질
아르헨티나
아랍에미리트(UAE)
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카/중동 및 아프리카
제10장 기업 개요
inomed Medizintechnik GmbH
NeuroStyle Pte Ltd.
Computational Diagnostics, Inc
Accurate Neuromonitoring, LLC(Housatonic Partners)
Medtronic PLC
SpecialtyCare, Inc(Morgan Stanley)
IntraNerve Neuroscience Holdings, LLC
Natus Medical Incorporated(Archimed SAS)
Globus Medical, Inc
Nihon Kohden Corporation
제11장 수술 중 신경 모니터링 시장을 위한 성공 필수 조건
LSH
영문 목차
영문목차
The Global Intraoperative Neuromonitoring Market size is expected to reach $7 billion by 2030, rising at a market growth of 6.0% CAGR during the forecast period.
Orthopedic surgeons frequently perform spinal surgeries, including spinal fusions, laminectomies, and discectomies. In these procedures, this neuromonitoring is vital for assessing the integrity of neural structures such as the spinal cord and nerve roots, ensuring their preservation during instrumentation and fusion processes. Consequently, the orthopedic surgery segment would acquire nearly 20% of the total market share by 2030. Orthopedic surgeries related to joint replacements, such as hip and knee replacements, may involve monitoring peripheral nerves to avoid injury during implantation. IONM provides valuable feedback to surgeons, helping prevent nerve damage and postoperative complications.
The overall growth in surgical procedures, including neurosurgery, orthopedics, and cardiovascular surgeries, significantly drives the demand for this neuromonitoring. As surgical volumes rise globally, so does the need for techniques that ensure the safety of critical neural structures. The adoption of minimally invasive surgical techniques is expanding across various medical specialties. In minimally invasive procedures, where direct visualization may be limited, this neuromonitoring provides real-time feedback to surgeons, contributing to the growth of IONM. Hence, the market is expanding significantly due to the increasing surgical procedures. Additionally, advancements in electrode technology have led to the development of high-resolution electrodes capable of capturing detailed neural signals. These electrodes provide clearer and more precise information about the functional integrity of neural structures during surgery. Surgeons and healthcare professionals can utilize these devices in various surgical settings, including ambulatory surgical centers and outpatient facilities. Advanced signal processing algorithms enhance the accuracy of data interpretation. Therefore, technological advancements in neuromonitoring technologies have been a pivotal factor in driving the growth of the market.
However, Regulatory bodies often impose stringent requirements for medical devices and procedures, including IONM systems. Manufacturers may find it difficult and expensive to meet these standards, which may delay the introduction of innovative technology. Smaller companies with innovative IONM solutions may face challenges navigating complex regulatory processes. This can create barriers to entry into the market for smaller enterprises, limiting competition and potentially hindering technological advancements. Hence, regulatory compliance and standardization are a significant challenge that hampers the growth of market.
Moreover, the availability of medical equipment, particularly IONM devices and accessories, was impacted by disruptions in the global supply chain. This led to delays in the procurement and maintenance of IONM systems. Hospitals and healthcare facilities faced the challenge of reallocating resources to manage the surge in COVID-19 cases. This resulted in a change in focus, emphasizing critical and emergency surgeries, which may affect the use of IONM in elective or non-urgent procedures. Thus, the COVID-19 pandemic had a moderate effect on the market.
By Source Type Analysis
Based on source type, the market is bifurcated into insourced monitoring and outsourced monitoring. The outsourced monitoring segment acquired a substantial revenue share in the market in 2022. Outsourced monitoring offers scalability and flexibility in adjusting monitoring services based on demand. Healthcare institutions can scale up or down their neuromonitoring services as needed without the constraints of maintaining a fixed in-house team. Outsourced monitoring services offer rapid deployment and on-demand availability. This can be particularly beneficial for healthcare facilities requiring immediate access to neuromonitoring services without delays associated with internal setup.
By End User Analysis
Based on end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs). The ambulatory surgical centers (ASCs) segment covered a considerable revenue share in the market in 2022. ASCs have experienced a steady rise in the volume of surgical procedures performed on an outpatient basis. As the demand for ambulatory surgery increases, so does the need for this neuromonitoring to enhance patient safety and surgical precision. ASCs prioritize patient-centric care, and integrating this neuromonitoring aligns with this focus. ASCs can provide advanced care alternatives in a patient-friendly environment by improving patient safety and lowering the risk of neurological problems. As ASCs increasingly adopt this neuromonitoring, surgeons and medical staff become more familiar with the technology. This familiarity fosters a positive environment for integrating IONM into a broader range of surgical procedures at ASCs.
By Products & Services Analysis
By products & services, the market is categorized into systems, accessories, and services. The accessories segment covered a considerable revenue share in the market in 2022. Specialized electrodes and sensors are crucial accessories in IONM. These components are directly applied to the patient to capture neural signals accurately. Advancements in electrode materials and designs contribute to improved signal quality and reduced interference, enhancing the overall reliability of IONM. Accessories that aid in precisely placing electrodes are essential for optimizing the monitoring process. These tools ensure accurate positioning, critical for obtaining reliable and meaningful neural data during surgery.
By Application Analysis
On the basis of application, the market is divided into spinal surgery, neurosurgery, orthopedic surgery, ENT surgery, vascular surgery, and others. The neurosurgery segment garnered a significant revenue share in the market in 2022. Neurosurgery involves highly intricate procedures within the brain and spinal cord. The complexity of these interventions necessitates precise monitoring of neural structures to avoid damage and ensure optimal outcomes. IONM provides real-time feedback to surgeons during neurosurgical procedures. Advances in neurosurgical techniques, including minimally invasive procedures and image-guided surgeries, are complemented by the integration of this neuromonitoring. The combined use of these technologies enhances the precision and safety of neurosurgical interventions.
By Modality Analysis
By modality, the market is classified into motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs). The electroencephalography (EEG) segment recorded a remarkable revenue share in the market in 2022. EEG is a valuable tool for monitoring brain function in real time. During surgeries, especially those involving the brain or procedures that may impact cerebral blood flow, EEG provides continuous feedback on the brain's electrical activity. EEG monitoring is extensively used in neurosurgical procedures, including brain tumor resections and epilepsy surgeries. Monitoring the EEG helps surgeons navigate critical brain regions and identify abnormal patterns, contributing to the success of these delicate procedures. EEG plays a crucial role in surgeries related to epilepsy, where precise localization of the epileptic focus is essential. Continuous EEG monitoring assists in identifying seizure activity and guides respective surgery or other interventions.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. North America boasts an advanced healthcare infrastructure with well-established medical facilities, research centers, and hospitals. The North American region witnesses a significant number of spinal surgeries, including procedures for degenerative spine conditions, herniated discs, and spinal fusions. The region experiences many orthopedic procedures, including joint replacements and complex orthopedic surgeries. The aging population in North America contributes to a higher demand for surgical interventions, particularly in neurosurgery and orthopedics.
List of Key Companies Profiled
Nihon Kohden Corporation
inomed Medizintechnik GmbH
Medtronic PLC
SpecialtyCare, Inc. (Morgan Stanley)
NeuroStyle Pte. Ltd.
Computational Diagnostics, Inc.
Accurate Neuromonitoring, LLC (Housatonic Partners)
Intranerve Neuroscience Holdings, Llc
Natus Medical Incorporated (Archimed SAS)
Globus Medical, Inc.
Global Intraoperative Neuromonitoring Market Report Segmentation
By Source Type
Insourced Monitoring
Outsourced Monitoring
By End User
Hospitals
Ambulatory Surgical Centers (ASCs)
By Products & Services
Services
Systems
Accessories
By Application
Spinal Surgery
Neurosurgery
Orthopedic Surgery
ENT Surgery
Vascular Surgery
Others
By Modality
Electromyography (EMG)
Electroencephalography (EEG)
Motor Evoked Potentials (MEPs)
Somatosensory Evoked Potentials (SSEPs)
Visual Evoked Potentials (VEPs)
Brainstem Auditory Evoked Potentials (BAEPs)
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Intraoperative Neuromonitoring Market, by Source Type
1.4.2 Global Intraoperative Neuromonitoring Market, by End User
1.4.3 Global Intraoperative Neuromonitoring Market, by Products & Services
1.4.4 Global Intraoperative Neuromonitoring Market, by Application
1.4.5 Global Intraoperative Neuromonitoring Market, by Modality
1.4.6 Global Intraoperative Neuromonitoring Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Global Intraoperative Neuromonitoring Market by Source Type
4.1 Global Insourced Monitoring Market by Region
4.2 Global Outsourced Monitoring Market by Region
Chapter 5. Global Intraoperative Neuromonitoring Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Ambulatory Surgical Centers (ASCs) Market by Region
Chapter 6. Global Intraoperative Neuromonitoring Market by Products & Services
6.1 Global Services Market by Region
6.2 Global Systems Market by Region
6.3 Global Accessories Market by Region
Chapter 7. Global Intraoperative Neuromonitoring Market by Application
7.1 Global Spinal Surgery Market by Region
7.2 Global Neurosurgery Market by Region
7.3 Global Orthopedic Surgery Market by Region
7.4 Global ENT Surgery Market by Region
7.5 Global Vascular Surgery Market by Region
7.6 Global Others Market by Region
Chapter 8. Global Intraoperative Neuromonitoring Market by Modality
8.1 Global Electromyography (EMG) Market by Region
8.2 Global Electroencephalography (EEG) Market by Region
8.3 Global Motor Evoked Potentials (MEPs) Market by Region
8.4 Global Somatosensory Evoked Potentials (SSEPs) Market by Region
8.5 Global Visual Evoked Potentials (VEPs) Market by Region
8.6 Global Brainstem Auditory Evoked Potentials (BAEPs) Market by Region
Chapter 9. Global Intraoperative Neuromonitoring Market by Region
9.1 North America Intraoperative Neuromonitoring Market
9.1.1 North America Intraoperative Neuromonitoring Market by Source Type
9.1.1.1 North America Insourced Monitoring Market by Region
9.1.1.2 North America Outsourced Monitoring Market by Region
9.1.2 North America Intraoperative Neuromonitoring Market by End User
9.1.2.1 North America Hospitals Market by Region
9.1.2.2 North America Ambulatory Surgical Centers (ASCs) Market by Region
9.1.3 North America Intraoperative Neuromonitoring Market by Products & Services
9.1.3.1 North America Services Market by Country
9.1.3.2 North America Systems Market by Country
9.1.3.3 North America Accessories Market by Country
9.1.4 North America Intraoperative Neuromonitoring Market by Application
9.1.4.1 North America Spinal Surgery Market by Country
9.1.4.2 North America Neurosurgery Market by Country
9.1.4.3 North America Orthopedic Surgery Market by Country
9.1.4.4 North America ENT Surgery Market by Country
9.1.4.5 North America Vascular Surgery Market by Country
9.1.4.6 North America Others Market by Country
9.1.5 North America Intraoperative Neuromonitoring Market by Modality
9.1.5.1 North America Electromyography (EMG) Market by Country
9.1.5.2 North America Electroencephalography (EEG) Market by Country
9.1.5.3 North America Motor Evoked Potentials (MEPs) Market by Country
9.1.5.4 North America Somatosensory Evoked Potentials (SSEPs) Market by Country
9.1.5.5 North America Visual Evoked Potentials (VEPs) Market by Country
9.1.5.6 North America Brainstem Auditory Evoked Potentials (BAEPs) Market by Country
9.1.6 North America Intraoperative Neuromonitoring Market by Country
9.1.6.1 US Intraoperative Neuromonitoring Market
9.1.6.1.1 US Intraoperative Neuromonitoring Market by Source Type
9.1.6.1.2 US Intraoperative Neuromonitoring Market by End User
9.1.6.1.3 US Intraoperative Neuromonitoring Market by Products & Services
9.1.6.1.4 US Intraoperative Neuromonitoring Market by Application
9.1.6.1.5 US Intraoperative Neuromonitoring Market by Modality